JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 48 filers reported holding JUNIPER PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 328,132 | $3,380,000 | 1.26% |
Krensavage Asset Management, LLC | 288,326 | $2,970,000 | 0.95% |
EAM Investors, LLC | 146,475 | $1,509,000 | 0.20% |
ALGERT GLOBAL LLC | 37,017 | $381,000 | 0.18% |
PERRITT CAPITAL MANAGEMENT INC | 73,000 | $752,000 | 0.16% |
GSA CAPITAL PARTNERS LLP | 174,064 | $1,793,000 | 0.09% |
Bellevue Asset Management AG | 50,000 | $515,000 | 0.08% |
Spark Investment Management LLC | 45,800 | $471,000 | 0.06% |
CADENCE CAPITAL MANAGEMENT LLC | 82,392 | $849,000 | 0.06% |
TFS CAPITAL LLC | 34,611 | $356,000 | 0.04% |